Headlines | WebDisclosure

BRIEF

published on 02/21/2026 at 12:05, 9 hours 57 minutes ago

Abivax Unveils Promising Obefazimod Data at ECCO 2026

Obefazimod Clinical Efficacy Safety Profile Inflammatory Bowel Disease Anti-Fibrotic Activity
BRIEF

published on 02/21/2026 at 12:05, 9 hours 57 minutes ago

Abivax dévoile des données prometteuses sur l'obefazimod lors du salon ECCO 2026

Obefazimod Efficacité Clinique Profil De Sécurité Maladie Inflammatoire De L'intestin Activité Antifibrotique
PRESS RELEASE

published on 02/21/2026 at 12:00, 10 hours 1 minute ago

Abivax présente, au Congrès de l’ECCO 2026, les premières preuves d’une activité antifibrotique d'obefazimod, ainsi que de nouvelles analyses de son efficacité et de sécurité dans les MICI
Abivax présente de nouvelles données sur l'efficacité clinique et l'activité antifibrotique d'obefazimod dans le traitement des maladies inflammatoires chroniques de l'intestin au Congrès de l'ECCO 2026

Abivax Obefazimod Maladie De Crohn Maladies Inflammatoires Fibrose
PRESS RELEASE

published on 02/21/2026 at 12:00, 10 hours 2 minutes ago

Abivax Presents First Evidence of Anti-Fibrotic Activity for Obefazimod Alongside New Clinical Efficacy and Safety Analyses in Inflammatory Bowel Disease at ECCO 2026
Abivax presents first evidence of anti-fibrotic activity for Obefazimod and new clinical efficacy and safety analyses in inflammatory bowel disease at ECCO 2026

Abivax Obefazimod Clinical Efficacy Inflammatory Bowel Disease Anti-fibrotic
PRESS RELEASE

published on 02/21/2026 at 12:00, 10 hours 2 minutes ago

Abivax présente, au Congrès de l’ECCO 2026, les premières preuves d’une activité antifibrotique d'obefazimod, ainsi que de nouvelles analyses de son efficacité et de sécurité dans les MICI
Abivax présente les preuves d’une activité antifibrotique d'obefazimod et de nouvelles analyses de son efficacité et de sécurité dans les MICI au Congrès de l’ECCO 2026

Abivax Obefazimod Sécurité Efficacité Clinique Activité Antifibrotique
BRIEF

published on 02/21/2026 at 00:50, 21 hours 12 minutes ago

Bocana Resources Corp. Extends Arizona Mining Claims LOI for Bulk Testing

Metallurgical Testing Letter Of Intent Bulk Sampling Arizona Claims Bocana Resources
BRIEF

published on 02/21/2026 at 00:50, 21 hours 12 minutes ago

Bocana Resources Corp. prolonge la lettre d'intention (LOI) de ses concessions minières en Arizona pour des essais en vrac.

Essais Métallurgiques Lettre D'intention Échantillonnage En Vrac Ressources De Bocana L'Arizona Revendique
PRESS RELEASE

published on 02/21/2026 at 00:45, 21 hours 17 minutes ago

Bocana Resources Corp. Extends Letter of Intent on Arizona Mining Claims for Additional Bulk Testing and Assay Review
Bocana Resources Corp. extends Letter of Intent for Arizona mining claims, plans bulk sampling and exploration permit acquisition

Letter Of Intent Arizona Exploration Permit Bulk Sampling Bocana Resources Corp.
BRIEF

published on 02/21/2026 at 00:35, 21 hours 27 minutes ago

Redwood AI Corp. Engages MCS for Marketing Services and Settles Debt

Debt Settlement Canadian Securities Exchange Securities Exchange MCS Market Communication Redwood AI Corp.
BRIEF

published on 02/21/2026 at 00:35, 21 hours 27 minutes ago

Redwood AI Corp. engage MCS pour des services de marketing et règle sa dette.

Règlement De Dettes Communication Marketing MCS Bourse Canadienne Des Valeurs Mobilières Redwood AI Corp. Bourse Des Valeurs

Published on 02/21/2026 at 00:45, 21 hours 17 minutes ago

Bocana Resources Corp. Extends Letter of Intent on Arizona Mining Claims for Additional Bulk Testing and Assay Review
Published on 02/21/2026 at 00:30, 21 hours 32 minutes ago

Redwood AI Corp. Announces Engagement for IR Services
Published on 02/20/2026 at 23:15, 22 hours 47 minutes ago

DigiPower X Announces Closing of Settlement
Published on 02/20/2026 at 23:00, 23 hours 2 minutes ago

Infinico Metals Corp. Announces Effective Date for 15-for-1 Common Share Consolidation
Published on 02/20/2026 at 22:17, 23 hours 45 minutes ago

Organto Foods Completes Warrant Exercise Incentive Program

View all ACCESSWIRE

Published on 02/21/2026 at 12:00, 10 hours 2 minutes ago

Abivax Presents First Evidence of Anti-Fibrotic Activity for Obefazimod Alongside New Clinical Efficacy and Safety Analyses in Inflammatory Bowel Disease at ECCO 2026
Published on 02/21/2026 at 12:00, 10 hours 2 minutes ago

Abivax présente, au Congrès de l’ECCO 2026, les premières preuves d’une activité antifibrotique d'obefazimod, ainsi que de nouvelles analyses de son efficacité et de sécurité dans les MICI
Published on 02/20/2026 at 18:36, 1 day 3 hours ago

EQS-Adhoc: innoscripta SE: Management Board Proposes Dividend of EUR 4.00 per Share
Published on 02/20/2026 at 18:31, 1 day 3 hours ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 02/20/2026 at 18:23, 1 day 3 hours ago

POS-Transaction in Own Shares

View all EQS

Published on 02/20/2026 at 19:29, 1 day 2 hours ago

SFPI GROUP: Liquidity agreement report S2 2025
Published on 02/20/2026 at 19:29, 1 day 2 hours ago

SFPI GROUP: bilan du contrat de liquidité S2 S025
Published on 02/20/2026 at 18:00, 1 day 4 hours ago

TERACT - Termination of liquidity agreement
Published on 02/20/2026 at 18:00, 1 day 4 hours ago

TERACT - Résiliation du contrat de liquidité
Published on 02/20/2026 at 17:35, 1 day 4 hours ago

CHIFFRE D'AFFAIRES 2025

View all LES ECHOS COMFI WIRE

News